Drug intelligence / Profile preview

misoprostol + isosorbide-5-mononitrate

Development stage
Phase 4
Lead developer
Cairo University
Modality
Small Molecules
Administration
Vaginal
01

Overview

Misoprostol + isosorbide-5-mononitrate is a combination therapy investigated for cervical ripening in women experiencing first-trimester pregnancy loss prior to surgical evacuation. Misoprostol is a synthetic prostaglandin E1 analog that induces cervical softening and uterine contractions by binding to prostaglandin receptors. Isosorbide-5-mononitrate is a nitric oxide donor that promotes cervical ripening by mimicking the natural inflammatory process of labor, leading to the degradation of collagen and reorganization of the extracellular matrix. This specific combination was evaluated in a clinical trial (NCT02738177) conducted by Cairo University to determine if the synergistic effect of a prostaglandin and a nitric oxide donor could improve cervical dilatation and consistency while reducing side effects compared to monotherapy.

Other names
misoprostol and isosorbide-5-mononitrate combinationmisoprostol + isosorbide mononitrate
02

Targets

PTGER2 (Prostaglandin E2 receptor EP2)PTGER3 (Prostaglandin E2 receptor EP3 subtype)PTGER4 (Prostaglandin E2 receptor EP4 subtype)sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on misoprostol + isosorbide-5-mononitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on misoprostol + isosorbide-5-mononitrate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call